TFE3 and neoplasm: Given that PRCC‐TFE3 upregulates HIF1α and HIF2α to regulate hypoxia‐related signatures in vivo (Figure 1E,F), we next investigated whether Hif1α and/or Hif2α are essential for tumor development.